Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Colavita

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Scientific Reports|April 24, 2022
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccineChiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Iscience|February 7, 2023
Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infectionFrancesca Colavita, Valentina Mazzotta, Gabriella Rozera, et al.
Journal of Medical Virology|June 12, 2023
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpoxValentina Mazzotta, Alessandro Cozzi-Lepri, Simone Lanini, et al.
Viruses|October 23, 2020
Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular AssayLicia Bordi, Giuseppe Sberna, Eleonora Lalle, et al.
Vaccines|September 27, 2025
Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case-Control StudyFrancesca Colavita, Concetta Castilletti, Giulia Matusali, et al.
The Lancet. Infectious Diseases|April 11, 2026
Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmissionFrancesca Colavita, Massimo Tempestilli, Silvia Meschi, et al.
Frontiers in Immunology|May 6, 2022
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
Open Forum Infectious Diseases|October 30, 2019
Rescue of Replication-Competent ZIKV Hidden in Placenta-Derived Mesenchymal Cells Long After the Resolution of the InfectionVeronica Bordoni, Eleonora Lalle, Francesca Colavita, et al.
International Journal of Molecular Sciences|November 13, 2025
Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID SubjectsEleonora Cimini, Alessandra Vergori, Claudia Cimaglia, et al.
Journal of Medical Virology|September 25, 2020
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2Annalisa Mondi, Eleonora Cimini, Francesca Colavita, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Scientific Reports|April 24, 2022
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccineChiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Iscience|February 7, 2023
Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infectionFrancesca Colavita, Valentina Mazzotta, Gabriella Rozera, et al.
Journal of Medical Virology|June 12, 2023
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpoxValentina Mazzotta, Alessandro Cozzi-Lepri, Simone Lanini, et al.
Viruses|October 23, 2020
Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular AssayLicia Bordi, Giuseppe Sberna, Eleonora Lalle, et al.
Vaccines|September 27, 2025
Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case-Control StudyFrancesca Colavita, Concetta Castilletti, Giulia Matusali, et al.
The Lancet. Infectious Diseases|April 11, 2026
Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmissionFrancesca Colavita, Massimo Tempestilli, Silvia Meschi, et al.
Frontiers in Immunology|May 6, 2022
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
Open Forum Infectious Diseases|October 30, 2019
Rescue of Replication-Competent ZIKV Hidden in Placenta-Derived Mesenchymal Cells Long After the Resolution of the InfectionVeronica Bordoni, Eleonora Lalle, Francesca Colavita, et al.
International Journal of Molecular Sciences|November 13, 2025
Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID SubjectsEleonora Cimini, Alessandra Vergori, Claudia Cimaglia, et al.
Journal of Medical Virology|September 25, 2020
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2Annalisa Mondi, Eleonora Cimini, Francesca Colavita, et al.
Pageof 13